(Q42249021)

19 October 2017

Amplification of a 280-kilobase core region at the ERBB2 locus leads to activation of two hypothetical proteins in breast cancer (English)

1 reference

19 October 2017

Amplification of a 280-Kilobase Core Region at the ERBB2 Locus Leads to Activation of Two Hypothetical Proteins in Breast Cancer (English)

1 reference

https://api.crossref.org/works/10.1016/S0002-9440(10)63556-0

Erb-b2 receptor tyrosine kinase 2

25 March 2024

main subject

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578197

25 March 2024

author name string

Päivikki Kauraniemi

1

1 reference

19 October 2017

Tuula Kuukasjärvi

2

1 reference

19 October 2017

Guido Sauter

3

1 reference

19 October 2017

Anne Kallioniemi

4

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

19 October 2017

http://ajp.amjpathol.org/article/S0002944010635560/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578197

https://europepmc.org/articles/PMC1892409

25 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578197

https://europepmc.org/articles/PMC1892409?pdf=render

25 March 2024

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578197

https://api.elsevier.com/content/article/PII:S0002944010635560?httpAccept=text/xml

25 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0002-9440(10)63556-0

https://api.elsevier.com/content/article/PII:S0002944010635560?httpAccept=text/plain

25 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0002-9440(10)63556-0

The American Journal of Pathology

25 March 2024

published in

1 reference

19 October 2017

163

1 reference

19 October 2017

5

1 reference

19 October 2017

1979-1984

1 reference

Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

Association of Grb7 with phosphoinositides and its role in the regulation of cell migration

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

Improved procedure for fluorescence in situ hybridization on tissue microarrays.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

HER-2 and choice of adjuvant chemotherapy in breast cancer

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

Multiple genes at 17q23 undergo amplification and overexpression in breast cancer

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

Molecular portraits of human breast tumours

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

Comparative genomic hybridization reveals complex genetic changes in primary breast cancer tumors and their cell lines

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

Amplification and overexpression of peroxisome proliferator-activated receptor binding protein (PBP/PPARBP) gene in breast cancer

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

Genome-wide analysis of DNA copy-number changes using cDNA microarrays

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapy

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

Isolation of a candidate gene, CAB1, for cholesterol transport to mitochondria from the c-ERBB-2 amplicon by a modified cDNA selection method

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

Recent progress in understanding mechanisms of mammalian DNA amplification

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

Molecular dissection of mammalian gene amplification: new mechanistic insights revealed by analyses of very early events

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

The LightCycler: a microvolume multisample fluorimeter with rapid temperature control.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

Impact of DNA amplification on gene expression patterns in breast cancer

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892409

Should selection of adjuvant chemotherapy for patients with breast cancer be based on erbB-2 status?

3 November 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963556-0

Effects of c-erbB2 overexpression on the drug sensitivities of normal human mammary epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963556-0

Co-amplification of erbB2, topoisomerase II alpha and retinoic acid receptor alpha genes in breast cancer and allelic loss at topoisomerase I on chromosome 20

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963556-0

New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14578197

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14578197

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14578197

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

19 October 2017

1 reference

19 October 2017

1 reference